New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Kezar Life Sciences, Inc.
KZR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

43M

Biotechnology

Next Earning date - 27 Mar 2025

43M

Biotechnology

Next Earning date - 27 Mar 2025

5.89USD

Shape0.31 ( 5.56%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-80%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

42%

Quote Panel

Shape
Updated March 24, 2025
1W 1.90 % 1M -2.64 % 3M -13.89 % 1Y -93.56 %

Key Metrics

Shape
  • Market Cap

    43.00M


  • Shares Outstanding

    7.30M


  • Share in Float

    6.22M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    5.89


  • Average Volume

    29415


  • Beta

    0.486


  • Range

    5.2-10.1


  • Industry

    Biotechnology


  • Website

    https://www.kezarlifesciences.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

KZR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

ShapeNaN%

2025-Revenue

$8.52

Shape-2943%

2025-EPS

$2M

Shape111%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

downgrade

Previous: Not converted

2024-10-02

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-2.50
vs -2.50

Q1.23

arrow
arrow

N/A

-3.10
vs -2.60

Q2.23

arrow
arrow

N/A

-3.40
vs -2.50

Q3.23

arrow
arrow

N/A

-3.20
vs -2.50

Q4.23

arrow
arrow

N/A

-3.50
vs -2.50

Q1.24

arrow
arrow

N/A

-3.00
vs -3.10

Q2.24

arrow
arrow

N/A

-2.80
vs -3.40

Q3.24

arrow
arrow

N/A

-2.78
vs -3.20

Q4.24

arrow
arrow

N/A

-2.72
vs -3.50

Q1.25

arrow
arrow

N/A

-2.62
vs -3.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

7M  vs NA

Q4.23

arrow
arrow

NA

-5428000.00  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

-100%

NA  vs 7M

Q4.24

arrow
arrow

+129%

1.6M  vs -5428000

Q1.25

arrow
arrow

NA

1.7M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-6%

-0.06
vs -0.06

Q1.23

arrow
arrow

-8%

-0.08
vs -0.06

Q2.23

arrow
arrow

-10%

-0.10
vs -0.08

Q3.23

arrow
arrow

-11%

-0.11
vs -0.10

Q4.23

arrow
arrow

-17%

-0.17
vs -0.11

Q1.24

arrow
arrow

-13%

-0.13
vs -0.17

Q2.24

arrow
arrow

-14%

-0.14
vs -0.13

Q3.24

arrow
arrow

-15%

-0.15
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

146

146
vs 126

16%

Q2.23

arrow
arrow

113

113
vs 146

-23%

Q3.23

arrow
arrow

89

89
vs 113

-21%

Q4.23

arrow
arrow

84

84
vs 89

-6%

Q1.24

arrow
arrow

86

86
vs 84

2%

Q2.24

arrow
arrow

78

78
vs 86

-9%

Q3.24

arrow
arrow

58

58
vs 78

-26%

Q4.24

arrow
arrow

1

1
vs 58

-98%

Earnings Growth

Latest News